References
1. COVID Data Tracker. CDC; 2021. https://covid.cdc.gov/covid-data-tracker/#datatracker-home.
2. American Academy of Pediatrics CsHA. Children and COVID-19: State-Level Data Report. 2021. Accessed June 23, 2021.
3. Zimmermann P, Curtis N. Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children. The Pediatric infectious disease journal. 2020;39(5):355-368.
4. Yelin D, Wirtheim E, Vetter P, et al. Long-term consequences of COVID-19: research needs. The Lancet Infectious Diseases.2020;20(10):1115-1117.
5. Carfì A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. Jama. 2020;324(6):603-605.
6. Abdallah SJ VN, Corrales-Medina VF, McGuinty M, Pratt A, Chopra A, Law A, Garuba HA, Thavorn K, Reid RER, Lavoie KL, Crawley A, Chirinos JA, Cowan J. Symptoms, Pulmonary Function and Functional Capacity Four Months after COVID-19. Annals of the American Thoracic Society.2021.
7. Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet.2021;397(10270):220-232.
8. Logue JK, Franko NM, McCulloch DJ, et al. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Network Open.2021;4(2):e210830-e210830.
9. Petersen MS, Kristiansen MF, Hanusson KD, et al. Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020.
10. Tenforde MW KS, Lindsell CJ, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020. MMWR and Morbidity and Mortality Weekly Report.2020;69:993-998.
11. Morin L, Savale L, Pham T, et al. Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19. Jama.2021;325(15):1525-1534.
12. Excellence NIfHaC. COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (UK); December 18, 2020 2020.
13. Stanojevic S, Wade A, Stocks J, et al. Reference ranges for spirometry across all ages: a new approach. Am J Respir Crit Care Med. 2008;177(3):253-260.
14. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. The European respiratory journal. 2005;26(2):319-338.
15. ATS Statement: Guidelines for the Six-Minute Walk Test.American Journal of Respiratory and Critical Care Medicine.2002;166(1):111-117.
16. Townsend L, Dowds J, O’Brien K, et al. Persistent Poor Health after COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity. Ann Am Thorac Soc. 2021;18(6):997-1003.
17. National Current Asthma Prevalence. CDC; 2019. https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm.
18. Robbins JM, Mallya G, Wagner A, Buehler JW. Prevalence, Disparities, and Trends in Obesity and Severe Obesity Among Students in the School District of Philadelphia, Pennsylvania, 2006-2013. Preventing chronic disease. 2015;12:E134.
19. Salman D, Vishnubala D, Le Feuvre P, et al. Returning to physical activity after covid-19. BMJ. 2021;372:m4721.
20. Arnold D, Milne A, Samms E, Stadon L, Maskell N, Hamilton F. Are vaccines safe in patients with Long COVID? A prospective observational study. medRxiv. 2021:2021.2003.2011.21253225.